Introduction {#Sec1}
============

RNA polymerase II transcription is a tightly regulated process in which the chromatin near the gene to be transcribed is re-organized and remodeled, followed by the formation of the transcription pre-initiation complex and the processes of initiation, elongation and termination. Different multi-protein complexes are involved in these processes for regulation under normal or stress conditions. A similar phenomenon of complex regulation occurs during cell cycle progression where many changes take place including modulation of the cytoskeleton (Sawin and Tran [@CR60]). Taf14 is one of the few proteins thought to play a role in all of these vital processes but its specific role is still unknown, and it is the focus of this work.

*TAF14* was first identified (as *ANC1*) in a screen for mutations that enhance defects caused by a mutation in the actin gene (Welch et al. [@CR75]). Cells devoid of Taf14 are viable but thermo- and osmo-sensitive (Henry et al. [@CR30]) have defects in actin organization (Welch et al. [@CR75]), and aberrant morphology and cytoskeletal defects (Henry et al. [@CR30]). Additionally, Taf14 is physically associated with a variety of transcription and chromatin remodeling complexes (Fig. [1](#Fig1){ref-type="fig"}a). It is present in, at least, three different ATP-dependent chromatin remodeling complexes: Swi/Snf, which possesses DNA-stimulated ATPase activity and activates transcription by helping transcription factors access their binding sites (Cairns et al. [@CR5]; Sudarsanam and Winston [@CR68]; Dechassa et al. [@CR14]); Ino80, which has helicase activity and is involved in transcription, replication and repair (Shen et al. [@CR63], [@CR64]; Conaway and Conaway [@CR8]); and RSC, essential for cell cycle progression (Du et al. [@CR15]; Eberharter et al. [@CR16]), and known for repositioning and ejecting nucleosomes from active sites (Parnell et al. [@CR55]). Taf14 also has been found in the histone--acetyltransferase complex, NuA3 (John et al. [@CR33]; Kabani et al. [@CR34]) that stimulates transcription or replication elongation through nucleosomes by providing a coupled acetyltransferase activity (John et al. [@CR33]). All of these complexes help transcriptional activators bind to occluded chromatin sites by perturbing histone--DNA contacts or by covalently modifying histones (Clark-Adams et al. [@CR6]; Imbalzano et al. [@CR32]; Steger et al. [@CR67]; Shen et al. [@CR62]; Neely and Workman [@CR52]; Cairns [@CR4]). Roles for these complexes were first identified in transcriptional regulation (Kingston and Narlikar [@CR38]; Davie and Kane [@CR13]; Narlikar et al. [@CR51]), but it has recently been shown that they also play diverse and complex roles in the DNA damage response (for review (Costelloe et al. [@CR11]; Park et al. [@CR54])).Fig. 1**a** Seven nuclear complexes that contain or bind Taf14. The sizes are not to scale. The names of the proteins tagged in this study from each of the complexes are shown. **b** Truncated versions of Taf14 used in this study: *TAF14, taf14\[YEATS\]* (amino acids 6--113), *taf14\[CT\]* (amino acids 113--244), and *taf14\[-NT\]* (amino acids 61--244). **c** Expression of the different Taf14 constructs. Equal amounts of cell extract were resolved on a 10% SDS-Laemmli protein gel and transferred to a nitrocellulose membrane for western blotting. Taf14 proteins were detected with Polyclonal Taf14 antibody. *Left paneltaf14Δ* strain (CMKy70) containing plasmids expressing Taf14 constructs under its natural promoter. The YEATS fragment (*Y* second line) is practically not detected. Empty plasmid was used as negative control, PGK protein as loading control. *Right paneltaf14Δ* strain (CMKy70) containing high copy plasmids expressing Tap-tagged Taf14 constructs under the PGK promoter. Empty pVV233 vector (TAP tag alone) was used as the negative control. The TAP tag is visible with the Taf14 antibody because it contains Protein A, recognized by IgG's in every polyclonal antibody. H+ vacuolar ATPase was used as loading control

Taf14 is also a subunit of the yeast transcription factors TFIID (Poon et al. [@CR56]) and TFIIF (Henry et al. [@CR30]; Cairns et al. [@CR5]) and seems to interact with TFIIB (Kimura and Ishihama [@CR37]). TFIID recognizes the TATA box or other promoter elements and enables the binding of TFIIB and TFIIA. It is also known to modify histones (Mizzen et al. [@CR48]; Cler et al. [@CR7]). TFIIF assists the recruitment of RNA polymerase II, TFIIE and TFIIH into the pre-initiation complex (Buratowski et al. [@CR3]; Flores et al. [@CR22], [@CR23]; Henry et al. [@CR30]). It is also involved in start site selection (Robert et al. [@CR58]; Majovski et al. [@CR45]; Khaperskyy et al. [@CR35]) and elongation (Robert et al. [@CR58]; Conaway et al. [@CR9]; Zhang et al. [@CR78]). Although a direct interaction has not always been detected (Kabani et al. [@CR34]), Taf14 has also been suggested as a component of the transcriptional activator Mediator (Kim et al. [@CR36]; Erlich et al. [@CR17]), a global regulator important in recruiting of the transcription machinery and modulating RNA polymerase II activity after the alteration of the chromatin template by remodelers (Myers and Kornberg [@CR50]; Baek et al. [@CR2]; He et al. [@CR29]). Supporting a role for Taf14 in initiation, in the *ADH1* gene (Krogan et al. [@CR40]) and the *GAL1* gene (Kabani et al. [@CR34]), Taf14 is recruited to the promoter region and not to the coding region, suggesting that Taf14 may be involved in the assembly of the RNA polymerase II pre-initiation complex. This recruitment is likely due to its presence in TFIID and TFIIF, but Taf14 also could have been recruited to that region through its association with the chromatin remodeling complexes described above.

In addition to the roles of Taf14 in chromatin remodeling and transcription initiation, in *Saccharomyces cerevisiae* there is a strong genetic interaction between Taf14 and the transcription elongation factor TFIIS (Fish et al. [@CR21]). TFIIS stimulates RNA polymerase II during elongation to recover from an arrested state by inducing the polymerase to cleave its nascent transcript, thus realigning the new RNA 3′ end in the active site (Fish and Kane [@CR20]; Ghavi-Helm et al. [@CR25]). Neither TFIIS nor Taf14 is essential, but the double mutant results in synthetic lethality (Davie and Kane [@CR13]; Fish et al. [@CR21]). These two proteins are not functionally redundant, but have a functional interaction within a cellular process, most likely during transcriptional elongation and in concert with TFIIF (Fish et al. [@CR21]). Taf14 (as well as proteins Gal1, Sua7, Rts1 or Tys1) has additionally been reported as a strong suppressor of the genetic interaction between *DST1* (the gene encoding for TFIIS) and SOH1 (when overexpressed) (Malagon et al. [@CR46]). *SOH1* is a member of Mediator and, in Saccharomyces, is synthetically lethal with mutations in genes encoding subunits of the RNA polymerase II, TFIIB (Fan et al. [@CR18]) and the histone H3 methyl transferase factor Set2 (Krogan et al. [@CR41]). Taf14 is also one of the 5% of intron containing genes in yeast and, surprisingly, splicing of its intron is necessary to suppress a temperature-sensitive cell cycle arrest of *cdc40Δ* cells (Dahan and Kupiec [@CR12]).

Taf14 contains a highly conserved YEATS domain at its N-terminus and along with Yaf9 and Sas5 comprises the YEATS domain family in yeast. The name for this domain derives from the first discovered proteins containing the domain (Yaf9, ENL, AF9, Taf14, Sas5) (Harborth et al. [@CR28]). Its function has not yet been described, but it is thought to be implicated in regulating transcription and chromatin remodeling (Schulze et al. [@CR61]). This domain is found in many eukaryotic species as diverse as *Arabidopsis*, *Drosophila*, *Caenorhabditis elegans,* yeast and human. ENL, AF-9 (Corral et al. [@CR10]) and Gas41 (Fischer et al. [@CR19]) are the most extensively studied human proteins in this group. These three proteins are directly implicated in leukemias and gliomas whether by fusion of their non-YEATS domain to a protein called MLL in the case of ENL and AF-9 (Adler et al. [@CR1]) or by amplification of its expression in the case of Gas41 (Munnia et al. [@CR49]; Park and Roeder [@CR53]). As mentioned above, the Taf14 YEATS domain presents striking homology with two other yeast nuclear proteins, Yaf9 and Sas5. Yaf9 is the ortholog of human Gas41, and is a component of the NuA4 HAT complex and the SWR1 complex, which deposits the histone variant H2A.Z (Le Masson et al. [@CR44]; Zhang et al. [@CR77]). Sas5 is a component of the SAS complex involved in chromatin silencing by acetylating free histones (Sutton et al. [@CR69]; Shia et al. [@CR65]).

Here, we present the first evidence that the YEATS domain of Taf14 exerts a negative effect on cell growth, and deletion of the YEATS domain results in a growth advantage under certain stress conditions. We further show that the C-terminus but not the YEATS domain of Taf14 is necessary and sufficient for the rescue of the synthetic lethality with TFIIS. Moreover, the C-terminus is also sufficient for association of Taf14 with the complexes involved in transcription and chromatin remodeling described above, revealing that the YEATS domain is not required for interaction with these complexes. These results suggest that, rather than a structural role, the YEATS domain has a regulatory function, possibly coordinating the transcription and replication processes during the cell cycle.

Materials and methods {#Sec2}
=====================

Plasmids, strains, genetic methods and media {#Sec3}
--------------------------------------------

The *S. cerevisiae* strains and plasmids used in this study are listed in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. Taf14 point mutations were generated based on oligonucleotide-directed mutagenesis (Kunkel et al. [@CR42]) using the "Quick Change" mutagenesis strategy, as directed by the manufacturer (Stratagene). *Escherichia coli* calcium-manganese-based transformations were used with the Top10 *E. coli* strain. Yeast cells were transformed using lithium acetate (Gietz et al. [@CR26]).Table 1Plasmids used in this studyPlasmidDescriptionReferencepDD67*Cla*I-*Eco*RI insert of *TAF14* (including 760 bp of 5′ UTR and 360 bp of 3′ UTR) in pRS316(Welch et al. [@CR75])pBS1539URA3-marked plasmid containing a C-terminal TAP tagging cassette(Puig et al. [@CR57])pCP3*Cla*I-*Bam*HI 5′ and *Eag*I-*Sac*I 3′ UTR fragment of *TAF*14 from pDD67 inserted into pRS316This studypCP4*Nde*I-*Bgl*II *taf*14\[*YEATS*\] fragment (aa 6--113 of *TAF*14) from pDD69 inserted into pCP3This studypCP5*Nde*I-*Bgl*II *taf*14\[*CT*\] fragment (aa 113--244 of *TAF*14) from pDD69 inserted into pCP3This studypCP6*Nde*I-*Bgl*II *taf*14\[-*NT*\] fragment (aa 61--244 of *TAF*14) from pDD69 inserted into pCP3This studypDD69*Bam*HI-*Eco*RI 760 bp insert of *TAF*14 in pGEX-2T(Welch and Drubin [@CR74])pJS02*Nde*I-*Bgl*II *taf*14\[*FL*\] fragment (aa 1--244 of *TAF*14) from pDD69 inserted into pCP3This studypJS03pCP6 with amino acid change R~67~A/D~71~AThis studypJS04pCP6 with amino acid change R~75~AThis studypJS05pCP6 with amino acid change E~77~A/E~78~A/Q~79~AThis studypJS06pCP6 with amino acid change W~81~A/F~84~AThis studypJS06-ApCP4 with amino acid change W~81~A/F~84~AThis studypJS07pCP6 with amino acid change W~81~AThis studypJS08pCP6 with amino acid change F~84~AThis studypJS09pCP6 with amino acid change D~87~AThis studypJS10pCP6 with amino acid change E~94~A/K~95~AThis studypJS11pCP6 with amino acid change E~98~A/R~99~A/K~100~AThis studypJS12pCP6 with amino acid change H~103~A/D~104~AThis studypJS13pCP6 with amino acid change Q~109~A/E~110~AThis studypJS14pCP6 with amino acid change E~113~A/E~115~AThis studypJS15pCP6 with amino acid change K~124~AThis studypJS16pCP6 with amino acid change E~129~A/E~130~AThis studypJS17pCP6 with amino acid change K~133~AThis studypJS18pJS02 with amino acid change R~67~A/D~71~AThis studypJS19pJS02 with amino acid change R~75~AThis studypJS20pJS02 with amino acid change E~77~A/E~78~A/Q~79~AThis studypJS21pJS02 with amino acid change W~81~AThis studypJS22pJS02 with amino acid change F~84~AThis studypJS23pJS02 with amino acid change D~87~AThis studypJS24pJS02 with amino acid change E~94~A/K~95~AThis studypJS25pJS02 with amino acid change E~98~A/R~99~A/K~100~AThis studypJS26pJS02 with amino acid change H~103~A/D~104~AThis studypJS27pJS02 with amino acid change Q~109~A/E~110~AThis studypJS28pJS02 with amino acid change E~113~A/E~115~AThis studypJS29pJS02 with amino acid change K~124~AThis studypJS30pJS02 with amino acid change E~129~A/E~130~AThis studypJS31pJS02 with amino acid change K~133~AThis studypJS32pJS02 with amino acid change R~67~A/D~71~A/E~77~A/E~78~A/Q~79~AThis studypJS33pJS02 with amino acid change K~161~A/K~163~A/K~166~AThis studypJS40pVV223 with TAP-*taf*14\[*FL*\]This studypJS41pVV223 with TAP-*taf*14\[*CT*\]This studypJS42pVV223 with TAP-*taf*14\[*YEATS*\]This studypJS47pCP5 with amino acid change K~161~A/K~163~A/K~166~AThis studypRS316URA3 f1 ori (*Nae*I) T7 prom. lacZ′/MCS T3 promt. pMB1 ori bla CEN6 ARSH4(Sikorski and Hieter [@CR66])pVV223Expression vector for N-terminal 4-TAP tagged fusion protein under *PGK* promt.(Van Mullem et al. [@CR71])Table 2Yeast strains used in this studyStrainGenotypeReferenceCH1305*MAT*a *ade2 ade3 ura3 leu2 lys2*C. HolmCMKy24*MAT*a *ade2 ade3 ura3 leu2 lys2 trp1::hisG dst1Δ::hisG-URA3-hisG*(Davie and Kane [@CR13])CMKy70*MAT***a***ade2 ade3 ura3 leu2 lys2 taf14Δ::kan*(Fish et al. [@CR21])CMKy91*MAT*a*/MATα dst1Δ::hisG/dst1Δ::hisG TAF14/taf14Δ::kan*(Fish et al. [@CR21])Ino80-flag ∆anc1*S288C MATa his3Δ200 leu2Δ met15Δ trp1Δ63 ura3Δ anc1Δ::HIS3 INO80-FLAG*X. ShenW303-1a*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1*R. RothsteinW303A*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14∆::ClonNAT*This studyW303A-Sas3*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14∆::ClonNAT FLAG-SAS3*This studyW303A-Snf5*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14∆::ClonNAT HA-SNF5*This studyW303A-Sth1*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14∆::ClonNAT FLAG-STH1*This studyW303A-Taf1*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14∆::ClonNAT FLAG-TAF1*This studyW303A-Tfg1*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14∆::ClonNAT FLAG-TFG1*This studyW303A-Taf2*MAT*a *ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14∆::ClonNAT FLAG-TAF2*This study

Media such as YPD or synthetic complete (SC) were prepared according to standard procedures (Guthrie et al. [@CR27]). All chemicals were from Sigma--Aldrich unless otherwise noted. SE media was prepared as SC but by substituting the nitrogen source with 1 g/L of glutamic acid (monosodium salt). G418 Sulfate was added to autoclaved YPD or SE media at a concentration of 200 μg/mL. ClonNAT (WERNER BioAgents) was added to autoclaved media at 100 μg/mL. 6-Azauracil (6-AU) was added to autoclaved media at a final concentration of 60 μg/mL; NaCl, KCl, and sorbitol were included at a final concentration of 0.9, 1.2 and 1.8 M, respectively. Benomyl was added immediately after autoclaving media at a concentration of 35 μg/mL, from a stock solution at 10 mg/mL in dimethyl sulfoxide.

For the growth studies on plates, cells in exponential phase were diluted to an OD~600~ of 0.1 and four serial 10× dilutions were made. The same volume of cells was applied onto YPD or SC-URA plates with or without additions as indicated in the text. Cells were grown at 24, 30, or 36°C. For the growth studies in liquid media, cells in early stationary phase were diluted to an OD~600~ of 0.05 and grown at 30°C. Samples were taken every 1 h. The mean of the doubling times was calculated with data from exponential phase (OD~600~ 0.18--2.0). All the *R*P^2P^ were larger than 0.9.

Strain recovery and tetrad analysis {#Sec4}
-----------------------------------

The ability of various *TAF14* constructs to complement the synthetic lethality in the *taf14Δdst1Δ* strain was determined by tetrad analysis of heterozygous diploids. After sporulation of the *TAF14/taf14Δ::kan*^*r*^*, dst1Δ::hisG/dst1Δ::hisG* diploid (CMKy91) containing the different *TAF14* constructs on a URA-marked plasmid, the tetrads were dissected onto YPD solid media (plate A) which was then incubated at 26°C for 5--7 days. The colony size at every spore position was noted. In the case of extremely small colonies, the cells were transferred to fresh YPD media (plate B) and incubated for 1 week at 26°C. Colonies on YPD were replica plated to SC-URA media with or without G418 to determine genotypes of the colonies.

Whole cell extract and protein analysis {#Sec5}
---------------------------------------

Cell extracts for protein expression analyses were made using the post-alkaline extraction method (Kushnirov [@CR43]).

Standard Western blotting conditions with SDS-PAGE gels were used (Sambrook and Russell [@CR59]). Protein was transferred to nitrocellulose at 100 mV for 1 h and processed for immunoblotting. Primary antibodies were used in the following concentration: polyclonal anti-Taf14, 1:1,000; monoclonal anti-Flag, M2 (Sigma), 1:1,000; monoclonal anti-H+-vacuolar ATPase (Molecular Probes), 1:5,000; anti-PGK (molecular Probes), 1:5,000; and monoclonal anti-HA, clone HA-7 (Sigma), 1:5,000. The secondary ECL^TM^ anti-rabbit IgG horseradish peroxidase (HRP) labeled antibody (Amersham) was used at 1:5,000, and the secondary ECL^TM^ anti-mouse IgG horseradish peroxidase labeled antibody (Amersham) was used at 1:10,000. The detection of the immobilized proteins conjugated to HRP labeled antibodies was made by using ECL Plus western blotting detection reagents (Amersham-GE Healthcare).

Immunofluorescence microscopy {#Sec6}
-----------------------------

Asynchronous early log phase yeast cells (5 mL) were fixed with 5% formaldehyde (from a 37% stock solution added directly to the culture) for 1 h at 25°C on a rotator. Formaldehyde was removed by washing twice with 2 mL 0.1 M potassium phosphate buffer (pH 7.5). Cells were resuspended in 1 mL 0.1 M potassium phosphate buffer (pH 7.5) and 500 μL of cell suspension was permeabilized by the addition of 1 μL 14 M β-mercaptoethanol and 5.1 μL 5 mg/mL Zymolyase 20T (USB). After digestion at 37°C for 35 min, the cells were pelleted, and resuspended in 500 μl 0.1 M potassium phosphate buffer (pH 7.5). Ten microliters of cell suspension was then applied to polylysine coated slides (Fisher) and air dried. After rehydrating by immersion in 1× PBS for 5 min, cells were fixed for 6 min in methanol and 30 s in acetone, both at −20°C. Cells were blocked with BLOTTO \[1× phosphate buffered saline (PBS), 0.05% Tween-20, 5% nonfat dry milk\] for 15 min at room temperature. Affinity purified anti-Taf14 antibody (kind gift of David Drubin, UC Berkeley) was added in BLOTTO at a 1:50 dilution. Incubations continued for 12--16 h at 4°C in a humidified chamber. After washing twice with BLOTTO, 15 min each, Alexa Fluor 488^®^ goat anti-rabbit IgG (H + L) (Molecular Probes) was added in BLOTTO at a 1:200 dilution. Incubations continued for 1 h at 25°C in the dark in a humidified chamber. Slides were washed twice for 15 min each in PBS. Slides were mounted in DABCO mounting medium (2.5% w/v DABCO, Sigma \#D-2522, 50 mM Tris pH 7.5, 90% glycerol) containing 2 μg/mL DAPI. Coverslips were sealed with nail polish and stored at 4°C in the dark.

Inmunoprecipitation {#Sec7}
-------------------

N-terminal TAP-tagged Taf14 constructs were made with GatewayP^TMP^ Cloning technology (Invitrogen) (Van Mullem et al. [@CR71]). Three entry clones were generated containing the Taf14 constructs: Taf14 (1--244), taf14\[CT\] (113--244) and taf14\[YEATS\] (6--113), following the manufacturer's instructions. From each clone, the ORF was subcloned into the high copy plasmid pVV223 creating N-terminal TAP-tagged expression clones under the *PGK* promoter.

Genomic N-terminal FLAG tagged Taf2, Sth1, Sas3, Ino80, Tfg1, Taf1 and genomic N-terminal HA-tagged Snf5 (strains: W303-A-Snf5, Ino80-FLAG, W303-A-Sth1, W303-A-Sas3, W303-A-Tfg1, W303-A-Taf1 and W303-A-Taf2) were transformed with the three different truncated TAP-*Taf14* mutants. The strains were grown in 150 mL SE-URA/ClonNAT/G418 to log phase. Next, 150 OD~600~ units were harvested (\~0.4 g pellet). The cell pellet was washed in 10 mL of cold PBS (130 mM NaCl, 7 mM Na~2~HPO~4~-2H~2~O, 3 mM NaH~2~PO~4~-2H~2~O adjusted to pH 7.0), pelleted again, and resuspended in 1 mL PBS. After another centrifugation, the cell pellet was resuspended in 0.6 mL TAP-Ca^2+^-Buffer \[50 mM Tris--Cl pH 7.5, 200 mM NaCl, 1.5 mM MgAc, 2 mM CaClB~2~, 0.15% NP40, 1 mM DTT and one mini protease inhibitor tablet (Roche) per 5 mL\], and the tube was filled with acid-washed glass beads (425--600 µm, Sigma). The cells were disrupted mechanically using a bead beater (BioSpec Products, Bartlesville, Oklahoma, USA) 5 times for 20 s with 1-min steps on ice in between. The glass beads were removed by centrifugation at 250 × *g*. The unbroken cells and the insoluble material were removed by centrifugation at 4°C, 20,000 × *g* for 20 min. The supernatant of each sample was mixed with 50 μL of TAP-Ca^2+^-Buffer equilibrated Calmodulin Affinity Resin (Stratagene) and incubated with rotating at 4°C for 60 min. The beads were pelleted and washed four times with 0.6 mL TAP-Ca^2+^-Buffer, rotating for 10 min during each wash. They were then resuspended in 100 μL 2× SDS sample buffer (50 mM Tris--Cl pH 6.8, 2% SDS, 10% glycerol, 0.025% bromophenol blue) and resolved on a 7.5% SDS-polyacrylamide gel. After transferring to a nitrocellulose membrane, the gel was immunoblotted with monoclonal antibody against FLAG or HA peptides, and a polyclonal antibody against Taf14 as described above under protein analysis.

Results {#Sec8}
=======

The YEATS domain inhibits growth under different stress conditions {#Sec9}
------------------------------------------------------------------

To dissect the functional regions of Taf14 and decipher the role of its N-terminal YEATS domain, we created several deletion mutants (Fig. [1](#Fig1){ref-type="fig"}b). All the mutants were expressed on a plasmid under *TAF14*'s own promoter and regulatory sequences in a *taf14* disruption strain. The expression of all mutant proteins was similar to wild type except for the taf14\[YEATS\] construct which was expressed or detected poorly (Fig. [1](#Fig1){ref-type="fig"}c, left panel). Despite this detection problem, there is no doubt of its expression as the phenotypes for this mutant are completely different than the phenotypes for the *taf14* deletion mutant (see below). The cellular localization of all the constructs was also studied and while the taf14\[CT\] and the taf14\[-NT\] proteins were located in the nucleus as was the wild-type protein (Fig. [2](#Fig2){ref-type="fig"}), taf14\[YEATS\] was practically undetectable with the Taf14 antibody (Fig. [2](#Fig2){ref-type="fig"}). This result is consistent with its low detection by Western blots (Fig. [1](#Fig1){ref-type="fig"}c, left panel).Fig. 2Fluorescence microscopy of *taf14* mutants' intracellular localization. *taf14Δ* cells containing different plasmids expressing Taf14 constructs under its natural promoter were fixed and immunostained with a polyclonal Taf14 antibody (*left panels*, *green*). The *center panels* show nuclei in DAPI stained cells (*blue*). The *right panels* show the result of merging the immunostaining and the DAPI staining. Pictures represent a single image plane following deconvolution. Cells contained the wild-type Taf14 (*top panel*); or the taf14\[CT\] construct (*second panel*); or the taf14\[-NT\] construct (*third panel*); or the taf14\[YEATS\] construct (*fourth panel*); or the empty vector pCP3 with the 5′ and 3′ UTR of Taf14 as a negative control to determine the background (*bottom panel*)

In synthetic media lacking uracil (SC-URA) at 30°C, cells expressing the Taf14 construct missing the complete YEATS domain (taf14\[CT\]) had a growth rate comparable to cells expressing wild-type Taf14. In contrast, cells expressing the YEATS domain alone (taf14\[YEATS\]) or a construct with partial deletion of the YEATS domain (taf14\[-NT\]) showed a diminished growth rate (Table [3](#Tab3){ref-type="table"}). In the case of cells expressing taf14\[YEATS\], the doubling time was 1.6 times slower than the *taf14Δ* mutant (CMKy70) and 2.8 times slower than wild-type cells. In addition, the lag phase of cells expressing taf14\[YEATS\] was more than four times longer than that of the wild-type cells (Table [3](#Tab3){ref-type="table"}).Table 3Doubling times and lag times prior to entering into exponential phaseStrainDoubling time (h)Lag phase (h)CMKy70/pJS02 (*TAF14*)2.60 ± 0.048.00 ± 0.50CMKy70/pCP5 (*taf14\[CT\]*)2.97 ± 0.187.56 ± 0.20CMKy70/pCP6 (*taf14\[-NT\]*)3.90 ± 0.7212.58 ± 2.01CMKy70/pJS06 (*taf14\[-NT*~*W81A/F84A*~*\]*)3.44 ± 0.2814.15 ± 2.23CMKy70/pCP4 (*taf14\[YEATS\]*)7.46 ± 1.9534.60 ± 11.13CMKy70/pJS06-A (*taf14\[YEATS*~*W81A/F84A*~*\]*)9.60 ± 2.3632.14 ± 8.01CMKy704.59 ± 1.0012.54 ± 2.45All the liquid cultures were started at OD~600~ 0.05 from cells in stationary phase and grown at 30°C in SC-URA, except for CMKy70 that was grown in SC media. Values are the average from at least four different cultures

The Taf14 deletion constructs were further tested for their ability to complement the temperature sensitivity of a *taf14* disruption strain CMKy70 (Table [4](#Tab4){ref-type="table"}, left panel). Taf14\[CT\] grew as well as wild type at 36°C (and at 24°C). In contrast, taf14\[YEATS\] could not complement the temperature sensitivity at 36°C. Interestingly, taf14\[-NT\] could partially complement the growth at 36°C as it did during growth at 30°C cited above. These phenotypes were fully recessive to wild-type Taf14 (Fig. S1).Table 4Relative growth with different chemical compounds of *taf14Δ* strain and strains expressing truncated versions of Taf14--NaCl (0.9 M)Benomyl (35 μg/mL)Caffeine (3 mM)6-AU (60 μg/mL)Formamide (2%)Mycoph. ac (25 μg/mL)24°36°24°36°24°36°24°36°24°36°24°36°24°36°CMKy70/pJS02 (TAF14)++++++++++++±+±++−++±CMKy70/pCP5 (taf14\[CT\])+++++++++++++++++±+++++±CMKy70/pCP6 (taf14\[-NT\])+±±−±±+±+−±−+−CMKy70/pCP4 (taf14\[YEATS\])±−−−±−±−±−−−−−−CMKy70+−−−±−±−±−−−−−Cells were spotted in 10× serial dilutions onto SC-URA plates containing the indicated concentrations of NaCl, benomyl, caffeine, 6-azauracil (6-AU), formamide, and mycophenolic acid (Mycoph. ac.). Cells were grown at 24 and 36°C for 3 days, except that the benomyl and 6-AU plates were compared after 5 and 6 days, respectively. All the conditions were repeated a minimum of three times++, growth the same as CMKy70/pJS02 (*TAF14*) on SC-URA at 24°C; +, slow growth; ±, very slow growth; −, no growth after 9 days

Since a *taf14* deletion strain is sensitive to different genotoxic stressors, we also tested the effect of the constructs on cell growth under different stress conditions (Table [4](#Tab4){ref-type="table"}; Fig. [3](#Fig3){ref-type="fig"}) at both permissive (24°C) and non-permissive (36°C) temperatures. As expected from the described results above, taf14\[CT\] showed no growth disadvantage compared to the wild-type strain. Unexpectedly however, it displayed a growth *advantage* under certain conditions. This advantage was pronounced in the presence of the microtubule destabilizing drug benomyl, as well as on formamide or caffeine at 36C. A less pronounced advantage was seen in the presence of the nucleotide depleting drug 6-azauracil (6-AU). In contrast, under all tested conditions taf14\[-NT\] allowed very slow or no growth while taf14\[YEATS\] could not complement the growth defects of the *taf14* disruption mutant (Table [4](#Tab4){ref-type="table"}). We conclude that under a wide range of conditions, the YEATS domain of Taf14 limits cell growth both alone and in the context of the wild-type protein. These results may also indicate that in wild-type cells, a negative function of the YEATS domain is being regulated. This possibility is further explored in the "[Discussion](#Sec12){ref-type="sec"}".Fig. 3Growth rates of the different taf14 truncated mutants. Growth comparison of CMKy70 containing Taf14, taf14\[CT\] or taf14\[-NT\] on a plasmid. Tenfold serial dilutions from exponential phase cells were plated onto SC-URA with or without the indicated drugs (concentrations as in Table [4](#Tab4){ref-type="table"}). Cells on SC-URA and SC-URA with formamide were photographed after 3 days growth; SC-URA with benomyl, after 5 days; SC-URA with 6-AU, after 6 days

Amino acids W81 and W84 form part of a putative regulator interaction site on the YEATS domain surface {#Sec10}
------------------------------------------------------------------------------------------------------

Given the possible regulatory role of the YEATS domain in the cell cycle, we decided to perform a mutagenic scan of the domain to localize sites within the YEATS domain that were important for its function. We used the *taf14\[-NT\]* construct since its sensitized phenotype allowed for the observation of mutations that resulted in either increased or decreased growth.

Knowing that charged amino acids are usually necessary for protein--protein interactions, ten different single, double, or triple alanine substitutions of charged amino acid residues were made in the *taf14\[-NT\]* construct (Fig. [4](#Fig4){ref-type="fig"}a; Table [1](#Tab1){ref-type="table"}). In addition, we created five different alanine substitutions of highly conserved residues hoping to target an essential docking site (Fig. [4](#Fig4){ref-type="fig"}a; Table [1](#Tab1){ref-type="table"}). We compared the growth of cells transformed with each of the mutants to that of the strain expressing taf14\[-NT\] on solid media. Fourteen of the mutants grew similarly to cells harbouring taf14\[-NT\] (data not shown). However, the double mutant W81A/F84A improved growth (Fig. [4](#Fig4){ref-type="fig"}b). In fact, the growth of this mutant became comparable to that of cells expressing the full length protein at 24, 30 and 37°C. W81A/F84A also showed slightly better growth than unmutagenized taf14\[-NT\] on both sorbitol and benomyl (data not shown). There was no significant difference between the protein levels of any of these taf14\[-NT\] mutants (Fig. S2), arguing against the fact that altered expression levels were responsible for the observed phenotypes. Furthermore, the conserved residues W81 and F84 are predicted to lie on the surface of Taf14 (confirmed by the prediction programs: 3D-PSSM and JNet Secondary Structure Prediction, and Wang et al. [@CR73]) suggesting that they are not serving a structural role, but instead are involved in binding interactions between Taf14 and other protein regulators.Fig. 4**a** Multiple sequence alignment of the carboxy terminal half of the YEATS domain of Taf14 (61--113 aa) compared with other YEATS family proteins. Conserved residues in *bold type*. The point mutations used in this study are marked below Taf14; the *grey boxes* correspond to aminoacids 81 and 84. **b** Quantitative growth comparison of cells with Taf14 mutant constructs. CMY70 (*taf14Δ*) strains containing either pJS02 (*TAF14*), pCP5 (*taf14\[CT\]*), pCP6 (*taf14\[-NT\]*), pJS06 (*taf14\[-NT*~*W81A-F84A*~*\]*), pCP4 (*taf14\[YEATS\]*) or pJS06-A (*taf14\[YEATS*~*W81A-F84A*~*\]*) were grown to exponential phase (OD~600~ of 0.8--2.0) and 10× serial dilution were plated onto SC-URA. Cells were grown at 24°C and after 3 days the plate was photographed

Interestingly, the same double mutant slightly decreased growth when incorporated into the YEATS construct itself (Table [3](#Tab3){ref-type="table"}) and had no impact on growth in either liquid or on solid media when inserted into the wild-type Taf14 protein. These results suggest that the putative YEATS domain interaction site extends beyond these two residues, perhaps along the fragment of the YEATS domain missing in the taf14\[-NT\] mutant.

Taf14 residues in the C-terminal domain are important for the synthetic lethal phenotype between *taf14Δ* and *dst1Δ* {#Sec11}
---------------------------------------------------------------------------------------------------------------------

Although *TAF14* is not essential, its deletion shows a synthetic lethality with deletion of *DST1,* the Taf14 protein is therefore required for the survival of cells lacking the transcript elongation factor TFIIS (encoded by *DST1*) (Fish et al. [@CR21]). To determine if the YEATS domain of Taf14 is required for this genetic interaction, we analyzed the different mutants of *TAF14* for their ability to complement the synthetic lethality between *taf14Δ* and *dst1Δ*. Plasmids containing the *taf14* deletion mutants (Fig. [1](#Fig1){ref-type="fig"}b) were transformed into the heterozygous *TAF14/taf14Δ::kan*^*r*^, *dst1Δ::hisG/dst1Δ::hisG* diploid strain and transformants were sporulated at 30°C (Fig. [5](#Fig5){ref-type="fig"}). The taf14\[YEATS\] construct did not complement the synthetic lethality of the double deletion mutant (Fig. [5](#Fig5){ref-type="fig"}b), and taf14\[-NT\] grew slowly, taking 5--7 days for the germinating spores to make visible colonies (Fig. [5](#Fig5){ref-type="fig"}c). However, taf14\[CT\] complemented to equal levels as the wild-type protein (Fig. [5](#Fig5){ref-type="fig"}d).Fig. 5Efficiency of different Taf14 constructs in complementing the synthetic lethality between dst1*Δ* and *taf14Δ*. Heterozygous diploids were transformed with plasmids containing the indicated Taf14 constructs. Tetrad analysis was carried out with each strain. *Grey boxes* represent the *taf14Δ/dst1Δ* double mutant. The *taf14∆::kan*^*r*^ spores were identified by their G418^r^ phenotype. The presence of the URA3 marked plasmid was determined by testing growth on SC-URA media. *White boxes* represent the *dst1Δ/TAF14* mutant. *Boxes with X* did not have spores. **a** Tetrad analysis following sporulation of CMKy91 containing pJS02 (*TAF14*). The tetrads were dissected onto YPD medium, and the plate was photographed after 2 days at 24°C. **b** Similar to **a** with plasmid pCP4 (*taf14\[YEATS\]*). Plates were photographed after 3 days at 24°C. **c** Similar to **a** with plasmid pCP6 (*taf14\[-NT\]*). Plates were photographed after 7 days at 24°C. **d** Similar to **a** with plasmid pCP5 (*taf14\[CT\]*). Plates were photographed after 3 days at 24°C. Even after 9 days, no growth was detectable in the *blank spots*

We also studied the ability of taf14\[CT\] or taf14\[-NT\] mutants to complement the temperature sensitivity in the *taf14Δdst1Δ* background (conferred by the absence of Taf14). As in the *taf14Δ* background (Fig. [3](#Fig3){ref-type="fig"}, left bottom panel), the *taf14Δdst1Δ* strain expressing the taf14\[CT\] construct grew as well as the strain expressing the wild-type construct at 36°C. But the cells containing the *taf14\[-NT\]* construct grew poorly although this protein was able to complement the temperature sensitivity.

We next tested the ability of point mutants in *taf14\[-NT\]* (Table [1](#Tab1){ref-type="table"}) to complement the synthetic lethality between *taf14Δ* and *dst1Δ* (Fig. [6](#Fig6){ref-type="fig"}). The double mutant W81A/F84A conferred a growth advantage in the *taf14Δdst1Δ* cells, as it did in the *taf14* null background (Fig. [4](#Fig4){ref-type="fig"}b). Surprisingly, in contrast to our result in the *taf14* null background, three additional mutations outside the YEATS domain conferred a growth advantage in the *taf14Δdst1Δ* background: K124A, E129A/E130A, and K133A, suggesting that these three C-terminal residues are particularly relevant for the *TAF14* and *DST1* genetic interaction. Thus, we concluded that genetic interaction between *TAF14* and *DST1* is not dependent on the YEATS domain of Taf14 either.Fig. 6Complementation of the *taf14Δ dst1Δ* synthetic lethality by the taf14\[-NT\*\] point mutants. CMKy91 (*taf14Δ dst1Δ*) cells containing either pJS02 (*TAF14*), pCP5 (*taf14\[CT\]*), pCP6 (*taf14\[-NT\]*) or one of the plasmids with point mutations in *taf14\[-NT\*\]* were plated in serial dilutions onto SC-URA and YPD plates. Cells were grown at 24°C for 3 days. Mutants that could rescue the taf14\[-NT\] slow growth phenotype are marked with *arrows*. The slight growth advantage seen for the H~103~A/D~104~A mutant in this figure was not reproducible

Taf14 interaction with proteins related to transcription and chromatin {#Sec12}
----------------------------------------------------------------------

To determine the region of Taf14 protein required for the physical interaction of Taf14 with RSC, Swi/Snf, Ino80, NuA3, TFIIF and TFIID, we performed small-scale interaction assays.

Proteins from each complex were FLAG- or HA-tagged in their chromosomal loci. Tagged proteins included: (1) Snf5, thought to coordinate the assembly and nucleosome-remodeling activities of Swi/Snf (Geng et al. [@CR24]); (2) Sth1, the DNA-dependent ATPase of RSC (Du et al. [@CR15]); (3) Sas3, the histone acetyl transferase catalytic subunit of NuA3 (John et al. [@CR33]; Howe et al. [@CR31]); (4) Ino80, the DNA-dependent ATPase of the Ino80 complex (Shen et al. [@CR63], [@CR64]); (5) Tfg1, the largest subunit of TFIIF that functions in transcription initiation and elongation (Fish et al. [@CR21]; Khaperskyy et al. [@CR35]); (6) Taf1, the largest subunit of TFIID, with histone acetyltransferase activity (Mizzen et al. [@CR48]) and involved in promoter binding and G1/S progression (Tansey and Herr [@CR70]); (7) Taf2, also a TFIID subunit, stabilizes TFIID binding to the core promoter (Walker et al. [@CR72]; Martinez et al. [@CR47]). The addition of the tag to these proteins did not affect the growth of these strains, suggesting that the tag did not impair function (data not shown).

Full length Taf14, taf14\[CT\] and taf14\[YEATS\] were TAP-tagged and expressed from plasmids under the *PGK* promoter (Fig. [1](#Fig1){ref-type="fig"}c, right panel). Each strain carrying one of the seven FLAG- or HA-tagged proteins was transformed with each of the three different Taf14-encoding plasmids. The incorporation of the Taf14 constructs into the different nuclear complexes was tested by immunoprecipitation experiments using the TAP tag on Taf14, followed by Western blotting with FLAG or HA antibodies to detect the protein in the complexes (Fig. [7](#Fig7){ref-type="fig"}).Fig. 7Interaction assay between Taf14 and different nuclear complexes. The same amount of soluble protein from extracts of *taf14Δ/FLAG-Tfg1, taf14Δ/FLAG-Sas3, taf14Δ/FLAG-Taf1, taf14Δ/FLAG-Taf2, taf14Δ/HA-Snf5, and taf14Δ/FLAG-Sth1* strains containing plasmids expressing either TAP-tagged wild-type Taf14 (pJS40), TAP-taf14\[CT\] (pJS41), or the TAP tag alone (pVV223) were processed as described in "[Materials and methods](#Sec2){ref-type="sec"}". The Western-blotted membranes were incubated with anti-FLAG M2 or anti-HA to visualize the protein representing each complex. The protein A present in the TAP tag allowed for the visualization of all versions of Taf14 (*black arrows*). *Red stars* mark the FLAG and HA-tagged proteins. (CT) represents the TAP-taf14\[CT\]. (FL) represents the TAP-Taf14. + indicates a cell extract of that strain without expression of Taf14 and was used as a positive control. − represents the negative control expressing the TAP tag alone

Both full length Taf14 and mutant taf14\[CT\] were associated with Swi/Snf, RSC, NuA3, TFIIF and TFIID (Fig. [7](#Fig7){ref-type="fig"}). We could draw no conclusions about the association with Ino80 as it could not be clearly detected in any of the five pull down experiments performed. Additionally, in the case of Swi/Snf, the Taf14\[CT\] was not always well incorporated and sometimes taf14\[CT\] appeared to immunoprecipitate more Taf2 than the full length protein itself. These results prevented us from making quantitative conclusions about the associations. Taf14\[YEATS\] was convincingly (three out of three experiments performed, data not shown) associated with Taf1, one of the TFIID components tested. However, in general the TAP-taf14\[YEATS\] peptide did not immunoprecipitate successfully and was not readily detected in association with the tested proteins even when the polyclonal anti-Taf14 antibody was used to maximize detection of the YEATS domain. Nevertheless, it is clear that the YEATS domain is not essential for Taf14's association with Swi/Snf, RSC, NuA3, TFIIF or TFIID.

Discussion {#Sec13}
==========

The work presented here explores the cellular function of Taf14 and studies the role of its conserved YEATS domain by structure--function and mutational analysis of various regions of Taf14. This protein is a member of at least six nuclear proteins complexes that are involved in transcription and chromatin modification (RSC, SWI/SNF, Ino80, NuA3, TFIIF, TFIID and possibly Mediator) (Henry et al. [@CR30]; Poon et al. [@CR56]; Cairns et al. [@CR5]; Du et al. [@CR15]; Shen et al. [@CR63], [@CR64]; Kabani et al. [@CR34]). Its deletion renders cells sensitive to high temperature and osmolarity, causes deficiency in both constitutive and induced transcription and leads to altered actin cytoskeleton (Welch et al. [@CR75]; Henry et al. [@CR30]; Kimura and Ishihama [@CR37]). The associations of Taf14 with different complexes and the resulting phenotypes of the disruption strain indicate that this protein might facilitate many nuclear processes in the cell, or that it links different processes to a general common mechanism. Exploring the cellular function of Taf14 and determining the role of its conserved YEATS domain was the focus of this work. We show that the YEATS domain has a negative role in cell growth, and it is not needed to bind the nuclear complexes that contain Taf14 nor to complement the Taf14 synthetic lethality with TFIIS when both proteins are absent from the cell.

In *S. cerevisiae*, there are three proteins that contain the YEATS domain (Taf14, Yaf9, Sas5), and cells require at least one of these proteins to survive (Zhang et al. [@CR77]). For this reason, when Taf14 deletion mutations in the YEATS domain were constructed, the initial expectation was that the YEATS domain would stimulate cell growth. However, contrary to expectations, we found that in all the cases tested, the C-terminal domain of Taf14 (taf14\[CT\]) was sufficient to complement all of the phenotypes of a *taf14* deletion strain. Furthermore, the YEATS domain deletion provides a growth *advantage* compared to wild-type cells under a variety of conditions (Table [3](#Tab3){ref-type="table"}; Fig. [3](#Fig3){ref-type="fig"}). In addition, a deletion of just the first 61 amino acids in the Taf14 YEATS domain (the taf14\[-NT\] construct) creates a strain with a growth disadvantage compared to a full deletion of the YEATS domain (aa 6--113, the taf14\[CT\] construct). These results, coupled with the extremely slow growth of cells expressing the YEATS domain alone, strongly suggest that the YEATS domain of Taf14 has an important negative regulatory function. We show that the YEATS domain is not needed for the association of Taf14 with any of the tested nuclear complexes (Fig. [7](#Fig7){ref-type="fig"}). This is consistent with the observation that only the coiled-coil C-terminal domain of Yaf9 is required for its interaction with Esa1, the histone acetyltransferase catalytic subunit of, NuA4, and not its YEATS domain (Zhang et al. [@CR77]). In the same way, the non-YEATS domain (also a coiled-coil region) of GAS41 is required for interaction with the human TIP60 and SRCAP complexes (Park and Roeder [@CR53]). Together, these observations suggest that the hypothesized negative effect of the YEATS domain would not be transmitted via the complexes themselves. While it is still formally possible that there may be interactions between Taf14 and other subunits of these complexes that are affected by deletion of the YEATS domain, we prefer a model where the YEATS domain functions outside of the complexes themselves, possibly by binding and modifying growth regulators through a specific binding site on its surface.

Compatible with the possibility that the YEATS domain contains such a regulatory motif, site-specific mutations (W81A, F84A) in the remaining YEATS residues of taf14\[-NT\] conferred a growth advantage to cells (Fig. [4](#Fig4){ref-type="fig"}b). These residues are predicted to reside in one of the loops of a β-sandwich, likely on the protein surface. Thus, this region might be critical for interaction with a protein or proteins in the cellular pathway in which the YEATS domain of Taf14 plays a role. The growth rescue of this sensitized mutant via these point mutations argues against the possible misfolding of the construct. This increased growth is not observed when the mutations are incorporated into the full length *TAF14,* but the reason for this result could be that we cannot detect increased growth over that of an already healthy strain. Since the YEATS domain is not required for interaction with at least five of the six complexes in which Taf14 is a subunit, these residues (W81 and F84) are unlikely to be necessary for interaction with the complexes themselves. It seems more likely that these residues are highlighting a regulatory region interacting with other proteins important for Taf14 function. Further, it seems plausible that the YEATS domain is carrying out a function separate from that of the C-terminal domain of Taf14.

Another feature of *TAF14* is that its disruption makes the gene encoding TFIIS (*DST1*) essential (Fish and Kane [@CR20]). TFIIS is a transcript elongation factor that allows RNA polymerase II to recover from the backtracked state and read through blocks to elongation such as the nucleosome (Kireeva et al. [@CR39]). The synthetic lethality between *TAF14* and *DST1* appears to be mediated through TFIIF, both an initiation and an elongation factor in transcription (Fish et al. [@CR21]). Both taf14\[CT\] and taf14\[-NT~W81A-F84A~\] complement the synthetic lethality in a *taf14Δdst1Δ* strain as effectively as wild-type Taf14 (Figs. [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}). In addition, three other mutants (K124A, E129A/E130A, or K133A) in the taf14\[-NT\] construct complement as well as wild-type Taf14 (Fig. [6](#Fig6){ref-type="fig"}). Interestingly, none of these residues are located in the YEATS domain, and these mutants do not rescue the slow growth phenotype of the taf14\[-NT\] mutant in the haploid *taf14Δ* strain. Thus, since these mutant residues do rescue the *taf14Δdst1Δ* synthetic lethality, they are residues that are needed specifically for the TFIIS function. This result reinforces the likelihood that the YEATS domain and the C-terminal domain are involved in distinct functions.

Disruption of *TAF14* also renders genes encoding subunits of SWI/SNF essential (Davie and Kane [@CR13]), and mutant alleles in the two larger subunits of TFIIF are also synthetically lethal with *taf14Δ* (unpublished results). It is possible that more of this type of genetic interaction might be found if direct experiments were done with genes in the other Taf14 bearing-complexes as well. Alternatively, the defects seen in *taf14* null mutants might be explained by disassembled complexes (one or more) or by assembled but functionally inactive complexes. For example, in a *snf5Δ* mutant, Swi/Snf is not well assembled leading to an inactive complex (Geng et al. [@CR24]). In contrast, *taf14Δ* mutants still contain a stable Swi/Snf complex with ATPase activity (Cairns et al. [@CR5]) and yeast TFIIF without Taf14 is still active in vitro (Ziegler et al. [@CR79]). In any case, Taf14's presence in the six nuclear complexes suggests that it might perform a broad function designed to enlist these complexes in particular processes or locations, perhaps at particular times. Clearly Taf14 is not needed in all circumstances as the complexes can function in its absence at the permissive temperature.

All these observations, together with several others found in the literature (see below), lead to plausible and testable hypotheses. First, it has been reported that the *taf14Δ* cells have elongated buds and actin hyperpolarization (Henry et al. [@CR30]), phenotypes often associated with cell cycle regulating proteins (Welch and Drubin [@CR74]). Second, cells lacking Taf14 spend much longer in G1 than do wild-type cells (Erlich et al. [@CR17]). Third, Taf14 is essential for the G2/M transition in *cdc40Δ* cells (Dahan and Kupiec [@CR12]), important for cell cycle progression. Fourth, Taf14 is related to two YEATS domain containing mammalian proteins Gas41 and AF-9, both implicated in spindle function. Fifth, Taf14 is a subunit of RSC, a chromatin remodeling complex also essential for cell cycle progression (Du et al. [@CR15]; Yamada et al. [@CR76]). Sixth, the YEATS domain containing protein Yaf9 is important for the deposition of H2A.Z (Le Masson et al. [@CR44]), a histone variant required for proper timing of transcription of cell cycle regulatory proteins. Along this line of thought, the results reported here also suggest a role for Taf14 and its YEATS domain during the cell cycle. While the doubling times of cells containing taf14\[-NT\] and YEATS constructs are longer than for cells containing the normal Taf14 or the taf14\[CT\] constructs, the lag time prior to starting cell division is profoundly increased, especially for cells containing the YEATS construct (Table [3](#Tab3){ref-type="table"}). This observation suggests a problem in reentering the cell cycle after stationary phase, perhaps from G~0~ to late G~1~ where cells commit to DNA replication. Additionally, the taf14\[CT\] mutant grows better than wild type in the presence of benomyl, a microtubule destabilizing drug (Fig. [3](#Fig3){ref-type="fig"}), as if the absence of the YEATS domain actually stabilized nuclear microtubules.

In summary, expression of only the YEATS domain makes the cells sick: a partial YEATS domain in Taf14 imparts slowed growth; a full deletion of the YEATS domain of Taf14 generates healthy cells. Additional experiments will be necessary to find the YEATS-binding regulator, to test, in a quantitative way, what fraction of each nuclear complex has Taf14 and the mutant versions bound, and to determine the importance of the YEATS domain for Taf14's function in the nucleus.
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Supplementary Fig. S1 Effect of taf14 mutants on a wild type strain. Same amounts of CH1305 containing TAP-TAF14 (pJS40), TAP-taf14\[CT\] (pJS41) and TAP-taf14\[YEATS\] (pJS42) on plasmids were grown onto SC-URA plates. The empty vector (pVV223) was used as a negative control (TIFF 1022 kb)

###### 

Supplementary 2 Fig. S2 Expression level of the different Taf14 mutant constructs in taf14Δ cells. Expression of different Taf14\[-NT\] mutants. Equal amounts of cell extract were resolved on a 10% SDS-Laemmli protein gel and transferred to a nitrocellulose membrane for western blotting. Proteins were detected with Polyclonal Taf14 antibody. W81A/F84A mutant, in red, is the only one showing an improved growth (Fig. 4) (TIFF 1796 kb)
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